Tanzania HIV Therapeutics Market Analysis

Tanzania HIV Therapeutics Market Analysis


$ 3999

The Tanzania HIV therapeutics market is expected to reach $xx Mn by 2030, up from $xx Mn in 2022, with a CAGR of xx% from 2022 to 2030. Local Players such as Quality Chemicals, Shelys Pharmaceuticals, and Kairuki Pharmaceuticals dominate the HIV therapeutics market in Tanzania. The government policies, funding, and initiatives by international organizations to manage HIV infections in the country propel the market. The HIV therapeutics market in Tanzania is divided into four segments: type, product, geography, end user, and distribution channel.

ID: IN10TZPH037 CATEGORY: Pharmaceuticals GEOGRAPHY: Tanzania AUTHOR: Dr. Vishwa Modhia

Buy Now

Tanzania HIV Therapeutics Market Analysis Summary

Tanzania is a country in East Africa bordering the Indian Ocean. The Tanzania HIV therapeutics market is expected to reach $xx Mn by 2030, up from $xx Mn in 2022, with a CAGR of xx% from 2022 to 2030.

Tanzania had a 4.5 % adult HIV/AIDS prevalence rate in 2020, with 1,700,000 HIV cases, ranking it 12th worldwide. According to the most recent WHO data, HIV/AIDS deaths in Tanzania reached 27,402 in 2020, accounting for 9.29 % of total deaths.

Tanzania ranks 19th in the world in terms of age-adjusted death rate (64.39 per 100,000 population). Tanzania ranks fourth among the top ten countries in the world in terms of HIV cases, with 1,700,000 HIV cases. In 2020, Tanzania spent 9.8 % of its GDP on healthcare.

Market Dynamics

Market Growth Drivers

Tanzania has invested in the Education Plus initiative to eradicate HIV in the country. Tanzania's investment in secondary schools should help to combat HIV by ensuring the education of girls and young women. These elements may entice new entrants into Tanzania's HIV therapeutics market.

Market Restraint

In Tanzania, specialized HIV/AIDS treatment is not available. Some hospitals provide counseling. In general, the healthcare system falls short of European standards. Tanzania's poverty rate was 26.4 % in 2018, and HIV is a disease that disproportionately affects people from low socioeconomic backgrounds. These factors could discourage new entrants into the Tanzanian HIV therapeutics market.

Competitive Landscape

Key Players

  • Kairuki Pharmaceuticals (TZA)
  • Shelys Pharmaceuticals (TZA)
  • Quality Chemicals (TZA)
  • Medisel (TZA)
  • Danadams Pharmaceuticals (TZA)
  • ViiV Healthcare
  • Bristol Myers Squibb
  • Merck & Co.
  • Gilead Sciences

Healthcare Regulations and Reimbursement Policies

Tanzania's Food and Drug Authority is in charge of HIV therapeutics regulation (TFDA). The TFDA is in charge of evaluating, registering, and monitoring all pharmaceuticals and medical devices, including those used in HIV treatment. HIV therapeutics in Tanzania is governed by the Medicines and Medical Devices Act and its accompanying regulations, which establish the legal framework for the registration, distribution, and use of pharmaceuticals and medical devices in the country.

In Tanzania, HIV therapeutics are reimbursed through the National Health Insurance Fund (NHIF) and the Tanzanian government's HIV/AIDS program. These programs aim to provide access to affordable and effective HIV therapeutics to people living with HIV in Tanzania, regardless of their socioeconomic status. The NHIF is a government-sponsored health insurance program that provides coverage to individuals and their dependents. The NHIF covers the cost of antiretroviral therapy (ART) for people living with HIV, including the cost of medication, laboratory tests, and hospitalization.

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

HIV Therapeutics Segmentation

By Types (Revenue, USD Billion):

  • Nucleoside-Analog Reverse Transcriptase Inhibitors (NRTIs)
  • Coreceptor Antagonists
  • Entry and Fusion Inhibitors
  • Integrase Inhibitors
  • Protease Inhibitors (PIs)
  • Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs)

By Distribution Channel (Revenue, USD Billion):

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Methodology for Database Creation

Our database offers a comprehensive list of healthcare centers, meticulously curated to provide detailed information on a wide range of specialties and services. It includes top-tier hospitals, clinics, and diagnostic facilities across 30 countries and 24 specialties, ensuring users can find the healthcare services they need.​

Additionally, we provide a comprehensive list of Key Opinion Leaders (KOLs) based on your requirements. Our curated list captures various crucial aspects of the KOLs, offering more than just general information. Whether you're looking to boost brand awareness, drive engagement, or launch a new product, our extensive list of KOLs ensures you have the right experts by your side. Covering 30 countries and 36 specialties, our database guarantees access to the best KOLs in the healthcare industry, supporting strategic decisions and enhancing your initiatives.

How Do We Get It?

Our database is created and maintained through a combination of secondary and primary research methodologies.

1. Secondary Research

With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects. This historical data serves as the foundation for our database. Our continuous process of gathering data involves:

  • Analyzing historical proprietary data collected from multiple projects.
  • Regularly updating our existing data sets with new findings and trends.
  • Ensuring data consistency and accuracy through rigorous validation processes.

With extensive experience in the field, we have developed a proprietary GenAI-based technology that is uniquely tailored to our organization. This advanced technology enables us to scan a wide array of relevant information sources across the internet. Our data-gathering process includes:

  • Searching through academic conferences, published research, citations, and social media platforms
  • Collecting and compiling diverse data to build a comprehensive and detailed database
  • Continuously updating our database with new information to ensure its relevance and accuracy

2. Primary Research

To complement and validate our secondary data, we engage in primary research through local tie-ups and partnerships. This process involves:

  • Collaborating with local healthcare providers, hospitals, and clinics to gather real-time data.
  • Conducting surveys, interviews, and field studies to collect fresh data directly from the source.
  • Continuously refreshing our database to ensure that the information remains current and reliable.
  • Validating secondary data through cross-referencing with primary data to ensure accuracy and relevance.

Combining Secondary and Primary Research

By integrating both secondary and primary research methodologies, we ensure that our database is comprehensive, accurate, and up-to-date. The combined process involves:

  • Merging historical data from secondary research with real-time data from primary research.
  • Conducting thorough data validation and cleansing to remove inconsistencies and errors.
  • Organizing data into a structured format that is easily accessible and usable for various applications.
  • Continuously monitoring and updating the database to reflect the latest developments and trends in the healthcare field.

Through this meticulous process, we create a final database tailored to each region and domain within the healthcare industry. This approach ensures that our clients receive reliable and relevant data, empowering them to make informed decisions and drive innovation in their respective fields.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


Last updated on: 26 April 2024
Updated by: Ritu Baliya

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up